169 related articles for article (PubMed ID: 35186998)
1. Metabolic Dysfunctions of Intestinal Fatty Acids and Tryptophan Reveal Immuno-Inflammatory Response Activation in IgA Nephropathy.
Wu H; Tang D; Yun M; Liu H; Huang S; Yun C; Hocher B; Zhang X; Liu F; Yin L; Dai Y
Front Med (Lausanne); 2022; 9():811526. PubMed ID: 35186998
[TBL] [Abstract][Full Text] [Related]
2. Gut Dysbiosis and Intestinal Barrier Dysfunction Promotes IgA Nephropathy by Increasing the Production of Gd-IgA1.
Tang Y; Zhu Y; He H; Peng Y; Hu P; Wu J; Sun W; Liu P; Xiao Y; Xu X; Wei M
Front Med (Lausanne); 2022; 9():944027. PubMed ID: 35872757
[TBL] [Abstract][Full Text] [Related]
3. Sialylation of IgG inhibits the formation of galactose-deficient IgA1-containing immune complexes and protects mesangial cells from injury in IgA nephropathy.
Liu Y; Li H; Yu H; Wang F; Jia J; Yan T
BMC Nephrol; 2022 Jan; 23(1):25. PubMed ID: 35016642
[TBL] [Abstract][Full Text] [Related]
4. Identification of a novel interplay between intestinal bacteria and metabolites in Chinese patients with IgA nephropathy via integrated microbiome and metabolome approaches.
Wu H; Tang D; Zheng F; Li S; Zhang X; Yin L; Liu F; Dai Y
Ann Transl Med; 2021 Jan; 9(1):32. PubMed ID: 33553325
[TBL] [Abstract][Full Text] [Related]
5. Role of metabolomic profile as a potential marker to discriminate membranous nephropathy from IgA nephropathy.
Qu Y; Wang Y; Hu Z; Su C; Qian C; Pan J; Zhu Y; Shi A
Int Urol Nephrol; 2024 Feb; 56(2):635-651. PubMed ID: 37452988
[TBL] [Abstract][Full Text] [Related]
6. A cross-sectional analysis of clinicopathologic similarities and differences between Henoch-Schönlein purpura nephritis and IgA nephropathy.
Sugiyama M; Wada Y; Kanazawa N; Tachibana S; Suzuki T; Matsumoto K; Iyoda M; Honda H; Shibata T
PLoS One; 2020; 15(4):e0232194. PubMed ID: 32324811
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive analysis of aberrantly expressed profiles of mRNA and its relationship with serum galactose-deficient IgA1 level in IgA nephropathy.
Liu Y; Liu X; Jia J; Zheng J; Yan T
J Transl Med; 2019 Sep; 17(1):320. PubMed ID: 31547815
[TBL] [Abstract][Full Text] [Related]
8. Development and validation of diagnostic models for immunoglobulin A nephropathy based on gut microbes.
Dong Y; Chen J; Zhang Y; Wang Z; Shang J; Zhao Z
Front Cell Infect Microbiol; 2022; 12():1059692. PubMed ID: 36569195
[TBL] [Abstract][Full Text] [Related]
9. Microbiome and metabolome analysis to clarify the interaction between the urine microbiota and serum metabolites in Chinese patients with immunoglobulin A nephropathy.
Li S; Ma C; Yang Y; Cai W; Dai W; Zhang X; Yin L; Tang D; Liu F; Dai Y
Ann Transl Med; 2022 Nov; 10(22):1230. PubMed ID: 36544661
[TBL] [Abstract][Full Text] [Related]
10. Altered serum metabolic profile in patients with IgA nephropathy.
Dong L; Tan J; Zhong Z; Tang Y; Qin W
Clin Chim Acta; 2023 Sep; 549():117561. PubMed ID: 37722576
[TBL] [Abstract][Full Text] [Related]
11. Alternative Complement Pathway Is Activated and Associated with Galactose-Deficient IgA
Chiu YL; Lin WC; Shu KH; Fang YW; Chang FC; Chou YH; Wu CF; Chiang WC; Lin SL; Chen YM; Wu MS
Front Immunol; 2021; 12():638309. PubMed ID: 34177889
[TBL] [Abstract][Full Text] [Related]
12. Secondary IgA Nephropathy Shares the Same Immune Features With Primary IgA Nephropathy.
Wang M; Lv J; Zhang X; Chen P; Zhao M; Zhang H
Kidney Int Rep; 2020 Feb; 5(2):165-172. PubMed ID: 32043030
[TBL] [Abstract][Full Text] [Related]
13. Pathogenic role of glycan-specific IgG antibodies in IgA nephropathy.
Zhao YF; Zhu L; Liu LJ; Shi SF; Lv JC; Zhang H
BMC Nephrol; 2017 Sep; 18(1):301. PubMed ID: 28969604
[TBL] [Abstract][Full Text] [Related]
14. High levels of gut-homing immunoglobulin A+ B lymphocytes support the pathogenic role of intestinal mucosal hyperresponsiveness in immunoglobulin A nephropathy patients.
Sallustio F; Curci C; Chaoul N; Fontò G; Lauriero G; Picerno A; Divella C; Di Leo V; De Angelis M; Ben Mkaddem S; Macchia L; Gallone A; Monteiro RC; Pesce F; Gesualdo L
Nephrol Dial Transplant; 2021 Feb; 36(3):452-464. PubMed ID: 33200215
[TBL] [Abstract][Full Text] [Related]
15. A Novel Biomarker for Post-Transplant Recurrent IgA Nephropathy.
Temurhan S; Akgul SU; Caliskan Y; Artan AS; Kekik C; Yazici H; Demir E; Caliskan B; Turkmen A; Oguz FS; Sever MS
Transplant Proc; 2017 Apr; 49(3):541-545. PubMed ID: 28340830
[TBL] [Abstract][Full Text] [Related]
16. Clinical Significance of Serum Galactose-Deficient IgA1 Level in Children with IgA Nephropathy.
Irabu H; Shimizu M; Kaneko S; Inoue N; Mizuta M; Ohta K; Yachie A
J Immunol Res; 2020; 2020():4284379. PubMed ID: 32537466
[TBL] [Abstract][Full Text] [Related]
17. Leukemia Inhibitory Factor Signaling Enhances Production of Galactose-Deficient IgA1 in IgA Nephropathy.
Yamada K; Huang ZQ; Raska M; Reily C; Anderson JC; Suzuki H; Kiryluk K; Gharavi AG; Julian BA; Willey CD; Novak J
Kidney Dis (Basel); 2020 May; 6(3):168-180. PubMed ID: 32523959
[TBL] [Abstract][Full Text] [Related]
18. Clinical Significance of Galactose-Deficient IgA1 by KM55 in Patients with IgA Nephropathy.
Zhang K; Li Q; Zhang Y; Shang W; Wei L; Li H; Gao S; Yan T; Jia J; Liu Y; Lin S
Kidney Blood Press Res; 2019; 44(5):1196-1206. PubMed ID: 31574506
[TBL] [Abstract][Full Text] [Related]
19. Glomerular Immunodeposits of Patients with IgA Nephropathy Are Enriched for IgG Autoantibodies Specific for Galactose-Deficient IgA1.
Rizk DV; Saha MK; Hall S; Novak L; Brown R; Huang ZQ; Fatima H; Julian BA; Novak J
J Am Soc Nephrol; 2019 Oct; 30(10):2017-2026. PubMed ID: 31444275
[TBL] [Abstract][Full Text] [Related]
20. Immunostaining of galactose-deficient IgA1 by KM55 is not specific for immunoglobulin A nephropathy.
Zhao L; Peng L; Yang D; Chen S; Lan Z; Zhu X; Yuan S; Chen G; Liu Y; Liu H
Clin Immunol; 2020 Aug; 217():108483. PubMed ID: 32479989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
